$1.335
-0.035[-2.55%]
Last update: 2:32PM Get Real Time Here
Clearside Biomedical
(NASDAQ:CLSD)Clearside Biomedical Stock (NASDAQ:CLSD), Analyst Ratings, Price Targets, Predictions
Clearside Biomedical Inc has a consensus price target of $5.29, established from looking at the 32 latest analyst ratings. The last 3 analyst ratings were released from Needham, HC Wainwright & Co., and JMP Securities on April 11, 2024, March 14, 2024, and March 13, 2024. With an average price target of $5 between Needham, HC Wainwright & Co., and JMP Securities, there's an implied 252.11% upside for Clearside Biomedical Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Needham
HC Wainwright & Co.
JMP Securities
Wedbush
Needham
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Clearside Biomedical
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/11/2024 | CLSD | Buy Now | Clearside Biomedical | $1.42 | 181.69% | Needham | — | → $4 | Reiterates | Buy → Buy | Get Alert |
| 03/14/2024 | CLSD | Buy Now | Clearside Biomedical | $1.42 | 322.54% | HC Wainwright & Co. | Yi Chen | → $6 | Reiterates | Buy → Buy | Get Alert |
| 03/13/2024 | CLSD | Buy Now | Clearside Biomedical | $1.42 | 252.11% | JMP Securities | Jonathan Wolleben | → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/13/2024 | CLSD | Buy Now | Clearside Biomedical | $1.42 | 181.69% | Wedbush | Liana Moussatos | $5 → $4 | Maintains | Outperform | Get Alert |
| 03/13/2024 | CLSD | Buy Now | Clearside Biomedical | $1.42 | 181.69% | Needham | Serge Belanger | → $4 | Reiterates | Buy → Buy | Get Alert |
| 11/14/2023 | CLSD | Buy Now | Clearside Biomedical | $1.42 | 322.54% | HC Wainwright & Co. | Yi Chen | → $6 | Reiterates | Buy → Buy | Get Alert |
| 11/06/2023 | CLSD | Buy Now | Clearside Biomedical | $1.42 | 322.54% | HC Wainwright & Co. | Yi Chen | → $6 | Reiterates | Buy → Buy | Get Alert |
| 08/15/2023 | CLSD | Buy Now | Clearside Biomedical | $1.42 | 252.11% | JMP Securities | Jonathan Wolleben | → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/15/2023 | CLSD | Buy Now | Clearside Biomedical | $1.42 | 322.54% | HC Wainwright & Co. | Yi Chen | → $6 | Reiterates | Buy → Buy | Get Alert |
| 08/15/2023 | CLSD | Buy Now | Clearside Biomedical | $1.42 | 181.69% | Needham | Serge Belanger | → $4 | Reiterates | Buy → Buy | Get Alert |
| 07/19/2023 | CLSD | Buy Now | Clearside Biomedical | $1.42 | 322.54% | HC Wainwright & Co. | Yi Chen | → $6 | Reiterates | Buy → Buy | Get Alert |
| 07/12/2023 | CLSD | Buy Now | Clearside Biomedical | $1.42 | 252.11% | JMP Securities | Jonathan Wolleben | → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 07/10/2023 | CLSD | Buy Now | Clearside Biomedical | $1.42 | 322.54% | HC Wainwright & Co. | Yi Chen | → $6 | Reiterates | Buy → Buy | Get Alert |
| 06/14/2023 | CLSD | Buy Now | Clearside Biomedical | $1.42 | 322.54% | JonesTrading | Sean Kim | → $6 | Initiates | → Buy | Get Alert |
| 06/01/2023 | CLSD | Buy Now | Clearside Biomedical | $1.42 | 322.54% | HC Wainwright & Co. | Yi Chen | → $6 | Reiterates | Buy → Buy | Get Alert |
| 05/12/2023 | CLSD | Buy Now | Clearside Biomedical | $1.42 | 322.54% | HC Wainwright & Co. | Yi Chen | → $6 | Reiterates | Buy → Buy | Get Alert |
| 04/28/2023 | CLSD | Buy Now | Clearside Biomedical | $1.42 | 322.54% | JMP Securities | Jonathan Wolleben | → $6 | Reiterates | → Market Outperform | Get Alert |
| 04/20/2023 | CLSD | Buy Now | Clearside Biomedical | $1.42 | 181.69% | Needham | Serge Belanger | → $4 | Reiterates | → Buy | Get Alert |
| 04/19/2023 | CLSD | Buy Now | Clearside Biomedical | $1.42 | 322.54% | HC Wainwright & Co. | Yi Chen | → $6 | Reiterates | → Buy | Get Alert |
FAQ
What is the target price for Clearside Biomedical (CLSD)?
The latest price target for Clearside Biomedical (NASDAQ: CLSD) was reported by Needham on April 11, 2024. The analyst firm set a price target for $4.00 expecting CLSD to rise to within 12 months (a possible 199.63% upside). 17 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Clearside Biomedical (CLSD)?
The latest analyst rating for Clearside Biomedical (NASDAQ: CLSD) was provided by Needham, and Clearside Biomedical reiterated their buy rating.
When was the last upgrade for Clearside Biomedical (CLSD)?
The last upgrade for Clearside Biomedical Inc happened on November 10, 2022 when Stifel raised their price target to $8. Stifel previously had a hold for Clearside Biomedical Inc.
When was the last downgrade for Clearside Biomedical (CLSD)?
There is no last downgrade for Clearside Biomedical.
When is the next analyst rating going to be posted or updated for Clearside Biomedical (CLSD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Clearside Biomedical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Clearside Biomedical was filed on April 11, 2024 so you should expect the next rating to be made available sometime around April 11, 2025.
Is the Analyst Rating Clearside Biomedical (CLSD) correct?
While ratings are subjective and will change, the latest Clearside Biomedical (CLSD) rating was a reiterated with a price target of $0.00 to $4.00. The current price Clearside Biomedical (CLSD) is trading at is $1.34, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.